ESSA Pharma Inc. (EPIX) Financials
Stock symbol EPIX is outdated, potentially delisted? Maybe it is available on other exchange?
EPIX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 110.5 million | 1.6 million |
| March 31, 2025 | 115.4 million | 1.9 million |
| Dec. 31, 2024 | 122.6 million | 3.9 million |
| Sept. 30, 2024 | 128.1 million | 3.5 million |
EPIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | -4.2 million | -633933 |
| March 31, 2025 | -6.8 million | 1.2 million |
| Dec. 31, 2024 | -6.5 million | 2.7 million |
| Sept. 30, 2024 | -3.4 million | 2.0 million |
EPIX Net Income
No data available :(
EPIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | - | - | - |
| March 31, 2025 | 113.9 million | - | 280201 |
| Dec. 31, 2024 | 120.6 million | - | 305043 |
| Sept. 30, 2024 | 126.8 million | - | 329260 |
EPIX Shares Outstanding
EPIX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | - | -531441 | 5.5 million | - |
| March 31, 2025 | - | 3.5 million | 4.1 million | - |
| Dec. 31, 2024 | - | 5.5 million | 4.4 million | - |
| Sept. 30, 2024 | - | 4.2 million | 3.8 million | - |
EPIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | - | - |
| March 31, 2025 | - | 24040 |
| Dec. 31, 2024 | - | - |
| Sept. 30, 2024 | - | - |
EPIX
Price: $0.20
52 week price:
Dividend Yield: 798.41%
Forward Dividend Yield: 839.96%
Dividend Per Share: 1.69 USD
Earnings Per Share: -0.58 USD
P/E Ratio: -0.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 44601
Ebitda: -1.8 millionMarket Capitalization: 10.0 million
Years Paying Dividends: 1